Market Cap (In USD)
5171.00
Revenue (In USD)
4813.05
Net Income (In USD)
-6457.61
Avg. Volume
78.4 Thousand
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 1.0E-6-1.0E-4
- PE
- -
- EPS
- -
- Beta Value
- -0.065
- ISIN
- US71715W1062
- CUSIP
- 71715W106
- CIK
- -
- Shares
- 517076000.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Distribution
- CEO
- Mr. Mackie A. Barch
- Employee Count
- -
- Website
- https://www.pharmageninc.com
- Ipo Date
- 2012-03-08
- Details
- Pharmagen, Inc. distributes specialty drugs to hospitals, acute care facilities, surgery centers, and other healthcare practitioners in the United States. The company sources and distributes specialty drugs, blood plasma derivatives, specialty products, vaccines, anti-infectives, and hard-to-find pharmaceuticals. It offers plasma derivatives for treating serious medical conditions, such as cancer, hemophilia, rheumatoid arthritis, multiple scleroses, blood disorders, hepatitis, and HIV; and specialty products for treating respiratory, oncology, cardiovascular, and hormonal syndromes. The company also manufactures and distributes health supplements, including Clotamin, a specialized over-the-counter multivitamin dietary supplement for patients on Warfarin. In addition, it sells traditional pharmaceuticals to its distribution customers, such as antibiotics, vaccines, and other oral and injectable pharmaceuticals; and specializes in the formulation of drugs. The company was formerly known as Sunpeaks Ventures, Inc. and changed its name to Pharmagen, Inc. in January 2013. Pharmagen, Inc. is based in Silver Spring, Maryland.
More Stocks
-
3508
-
0IL6F5, Inc.
0IL6
-
002031
-
2761
-
6153
-
GOAU3Metalurgica Gerdau S.A.
GOAU3
-
AXFOAxfood AB (publ)
AXFO
-
ASAHIINDIAAsahi India Glass Limited
ASAHIINDIA